{
    "eid": "2-s2.0-85102201123",
    "title": "Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Nungruthai Nilsri",
        "Panchalee Jangprasert",
        "Jaturawat Pawinwongchai",
        "Nipan Israsena",
        "Ponlapat Rojnuckarin"
    ],
    "citedby-count": 4,
    "ref-count": 41,
    "ref-list": [
        "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia",
        "Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms",
        "Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms",
        "Myeloproliferative neoplasms: A contemporary review",
        "Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders",
        "Recent updates on induced pluripotent stem cells in hematological disorders",
        "Promise and challenges of human iPSC-based hematologic disease modeling and treatment",
        "Induced pluripotent stem cells in hematology: Current and future applications",
        "Hematopoietic specification from human pluripotent stem cells: Current advances and challenges toward de novo generation of hematopoietic stem cells",
        "Modeling myeloproliferative neoplasms: From mutations to mouse models and back again",
        "Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation",
        "Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms",
        "Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patients",
        "JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis",
        "A novel role for STAT1 in regulating murine erythropoiesis: Deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution",
        "Analysis of Jak2 signaling reveals resistance of mouse embryonic hematopoietic stem cells to myeloproliferative disease mutation",
        "Induced pluripotent stem cell technology: A decade of progress",
        "Mechanisms of action of interferon and nucleoside analogues",
        "Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: Minimal residual disease and cure?",
        "The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon \u03b1 2a target JAK2V617F-positive progenitor and stem cells",
        "Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway",
        "Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha",
        "Molecular targets of arsenic trioxide in malignant cells",
        "Specific and synergistic targeting of JAK2V617F cells by interferon alpha and arsenic",
        "Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia",
        "Metabolism, toxicity and anticancer activities of arsenic compounds",
        "Qualitative and quantitative comparison of the proteome of erythroid cells differentiated from human iPSCs and adult erythroid cells by multiplex TMT labelling and nanoLC-MS/MS",
        "Induced pluripotent stem cell-derived red blood cells and platelet concentrates: From bench to bedside",
        "Wiskott\u2013Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation",
        "A doxycycline-inducible system for genetic correction of iPSC disease models",
        "Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant",
        "Ghrelin promotes differentiation of human embryonic stem cells into cardiomyocytes",
        "Robust generation of hemangioblastic progenitors from human embryonic stem cells",
        "Gorlin syndrome-derived induced pluripotent stem cells are hypersensitive to hedgehog-mediated osteogenic induction",
        "Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation",
        "Multicolor staining of globin subtypes reveals impaired globin switching during erythropoiesis in human pluripotent stem cells",
        "Molecular analysis of globin gene expression in different thalassaemia disorders: Individual variation of beta(E) pre-mRNA splicing determine disease severity",
        "Definitive hematopoietic multipotent progenitor cells are transiently generated from hemogenic endothelial cells in human pluripotent stem cells",
        "Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells",
        "Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo",
        "Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73\u2013p53AIP1 apoptotic pathway in leukemia cells"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60023366",
            "affilname": "Rangsit University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pitsanulok",
            "@id": "60022498",
            "affilname": "Naresuan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022498",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}